Act
Prior Authorization Reform Act
- 215 ILCS 200/1— Short title
- 215 ILCS 200/5— Purpose
- 215 ILCS 200/10— Applicability; scope
- 215 ILCS 200/15— Definitions
- 215 ILCS 200/20— Disclosure and review of prior authorization requirements
- 215 ILCS 200/25— Health insurance issuer's and its contracted utilization review organization's obligations with respect to prior authorizations in nonurgent circumstances
- 215 ILCS 200/30— Health insurance issuer's and its contracted utilization review organization's obligations with respect to prior authorizations concerning urgent health care services
- 215 ILCS 200/35— Personnel qualified to make adverse determinations of a prior authorization request
- 215 ILCS 200/40— Requirements for adverse determination
- 215 ILCS 200/45— Requirements applicable to the personnel who can review appeals
- 215 ILCS 200/50— Review of prior authorization requirements
- 215 ILCS 200/55— Denial or penalty
- 215 ILCS 200/60— Length of prior authorization approval
- 215 ILCS 200/65— Length of prior authorization approval for treatment for chronic or long-term conditions
- 215 ILCS 200/70— Continuity of care for enrollees
- 215 ILCS 200/75— Health care services deemed authorized if a health insurance issuer or its contracted utilization review organization fails to comply with the requirements of this Act
- 215 ILCS 200/77— Prior authorization for drug therapies for hereditary bleeding disorders
- 215 ILCS 200/80— Severability
- 215 ILCS 200/85— Administration and enforcement
- 215 ILCS 200/900— (Amendatory provisions; text omitted)
- 215 ILCS 200/905— (Amendatory provisions; text omitted)
- 215 ILCS 200/910— (Amendatory provisions; text omitted)
- 215 ILCS 200/999— Effective date